Glossary
One hundred terms used in the twelve domains. Where a gloss points at another page, that page holds the sourced sentence.
Active pharmaceutical ingredient
Section titled “Active pharmaceutical ingredient”The substance intended to have a pharmacological effect in a finished drug, as distinct from excipients.
Adverse event
Section titled “Adverse event”An untoward medical occurrence in a person using a product. It is not, by itself, proof the product caused it.
Assistive product
Section titled “Assistive product”WHO uses this term for products that maintain or improve functioning. See the WHO page for the fact sheet.
Biohacking
Section titled “Biohacking”A loose popular label for self-directed experiments on body, data, or biology. This wiki does not treat the label as a method.
Biomarker
Section titled “Biomarker”A measured characteristic used as an indicator of a biological state. A wearable estimate is not automatically a validated biomarker.
Brain-computer interface
Section titled “Brain-computer interface”A system that translates brain signals into commands for a computer or machine. Performance claims need a study.
Breakthrough Device
Section titled “Breakthrough Device”A U.S. FDA device program. Eligibility and the specific device must be checked on an FDA record, which is not copied here.
Bulk drug substance
Section titled “Bulk drug substance”FDA’s term for an active ingredient used in compounding. Listing status has to be read from the FDA page.
Category 2
Section titled “Category 2”On FDA’s interim compounding lists, a category for nominated bulk substances FDA says may pose significant safety risks.
Certificate of analysis
Section titled “Certificate of analysis”A manufacturer’s document reporting tests on a batch. It is not an independent regulatory approval.
Current good manufacturing practice. The exact regulatory text depends on the product type and was not pasted here.
ClinicalTrials.gov
Section titled “ClinicalTrials.gov”The U.S. trial registry. A page on this wiki should cite an NCT record rather than summarize a trial from memory.
Cochlear implant
Section titled “Cochlear implant”An implanted device the International Neuromodulation Society names as an example of restoring a sensory function.
Compounded drug
Section titled “Compounded drug”A drug prepared by compounding. FDA says compounded drugs are not FDA-approved.
Continuous glucose monitor
Section titled “Continuous glucose monitor”A device that tracks glucose over time. Accuracy and whether a given product is a medical device are not stated in this glossary.
Deep brain stimulation
Section titled “Deep brain stimulation”Electrical stimulation through electrodes placed in deep brain targets. The neuromodulation page attributes examples to the INS.
De Novo
Section titled “De Novo”A U.S. FDA pathway for novel devices. A classification decision has to be read from an FDA record.
Do-it-yourself biology
Section titled “Do-it-yourself biology”Laboratory or community work done outside a conventional institution. This wiki does not describe how to do it.
Electroencephalography
Section titled “Electroencephalography”Recording electrical activity of the brain from electrodes. EEG is the usual abbreviation.
Electrocorticography
Section titled “Electrocorticography”Recording electrical activity from electrodes on the surface of the brain. Specifications are not given here.
Electromyography
Section titled “Electromyography”Recording electrical activity from muscle. Prosthetic control uses of EMG are not instructed here.
Endotoxin
Section titled “Endotoxin”A bacterial product that can contaminate injectable drugs. Numeric limits are not stated in this glossary.
Epigenetic clock
Section titled “Epigenetic clock”A model that estimates age-related state from epigenetic measurements. No clock’s error is stated here.
Evidence grade
Section titled “Evidence grade”This wiki’s A–E scale, from human randomized trials down to anecdote. Unrated means the design was not cited.
Exoskeleton
Section titled “Exoskeleton”A wearable frame that supports or moves limbs. Device claims are not stated in this glossary.
Functional near-infrared spectroscopy
Section titled “Functional near-infrared spectroscopy”An optical method for inferring brain blood-oxygen changes. fNIRS is the usual abbreviation.
General wellness policy
Section titled “General wellness policy”An FDA policy area for low-risk products that promote a general state of health. The policy text was not pasted here.
Glucagon-like peptide-1. On this wiki the drug-class notes are limited to the FDA page linked from the GLP-1 article.
Glucose-dependent insulinotropic polypeptide. This glossary does not assign drugs to this target.
Glucagon
Section titled “Glucagon”A pancreatic hormone that raises blood glucose. Receptor-agonist claims for specific drugs are not made here.
Heart-rate variability
Section titled “Heart-rate variability”Variation in the time between heartbeats. A wearable’s estimate needs its own validation study.
High-performance liquid chromatography
Section titled “High-performance liquid chromatography”A laboratory separation method often used in purity testing. This glossary sets no pass-fail cutoff.
Hypoactive sexual desire disorder
Section titled “Hypoactive sexual desire disorder”The desire disorder named in the VYLEESI labeling summarized on the bremelanotide page.
Investigational device exemption
Section titled “Investigational device exemption”A U.S. FDA framework for studying a significant-risk device in people. Study details are not copied here.
Implant
Section titled “Implant”A device or object placed inside the body. This wiki does not describe how to implant anything.
Import alert
Section titled “Import alert”An FDA instruction to detain specified products at the border. Import Alert 66-80 has its own page.
Informed consent
Section titled “Informed consent”A person’s agreement to an intervention or study after being told the relevant risks. Forms are not supplied here.
Intracortical array
Section titled “Intracortical array”Electrodes that penetrate brain cortex. Channel counts and brand performance are not stated here.
Invasiveness
Section titled “Invasiveness”How far a device enters the body. This wiki uses invasive, minimally invasive, and non-invasive as filing labels only.
Lyophilization
Section titled “Lyophilization”Freeze-drying. This wiki does not give preparation steps for a lyophilized peptide.
Mass spectrometry
Section titled “Mass spectrometry”A method that measures mass-to-charge ratios, often used to check identity. No acceptance rule is stated here.
Medical device
Section titled “Medical device”A regulated product intended for diagnosis or treatment. Whether a gadget is a device depends on its claims and the law.
Melanocortin receptor
Section titled “Melanocortin receptor”The receptor class named on the VYLEESI labeling for bremelanotide. Subtypes are not listed here.
Motor imagery
Section titled “Motor imagery”Imagining a movement without performing it, a paradigm used in some EEG interfaces. Accuracy is not stated.
Myoelectric control
Section titled “Myoelectric control”Using muscle electrical signals to command a prosthesis. Training steps are not described.
NCT number
Section titled “NCT number”The identifier ClinicalTrials.gov assigns to a study record, in the form NCT followed by digits.
Neurofeedback
Section titled “Neurofeedback”A training setup that shows a person a signal derived from their own nervous system. Benefit claims are not stated.
Neuromodulation
Section titled “Neuromodulation”The International Neuromodulation Society’s definition is summarized on the neuromodulation page.
Neuroprosthesis
Section titled “Neuroprosthesis”A device that replaces or assists a neural function. This glossary does not rank products.
Nootropic
Section titled “Nootropic”A popular label for substances used in the hope of changing cognition. It is not a regulatory category on this page.
Off-label use
Section titled “Off-label use”Use of an approved product for a purpose or population not in its labeling. This wiki does not recommend it.
Orthosis
Section titled “Orthosis”An external device that supports a body part, as distinct from a prosthesis that replaces one.
Osseointegration
Section titled “Osseointegration”Attachment of an implant to bone. Surgical technique is not described.
An event-related brain response used in some EEG spelling interfaces. Bit rates are not stated.
Pattern recognition control
Section titled “Pattern recognition control”Classifying sensor signals to choose a prosthesis movement. Algorithms are not specified.
Peptide
Section titled “Peptide”A short chain of amino acids. This wiki’s peptide pages do not provide doses or preparation steps.
Pharmacovigilance
Section titled “Pharmacovigilance”The collection of safety reports after a product is in use. A report is not automatic proof of cause.
Premarket approval
Section titled “Premarket approval”The U.S. FDA approval route for the highest-risk devices. A PMA number has to be checked on an FDA record.
Prosthesis
Section titled “Prosthesis”A device that replaces a missing body part. WHO’s fact sheet names prosthetic limbs among assistive products.
Quantified self
Section titled “Quantified self”The practice of recording personal data to understand one’s own life. The community site was not summarized.
Randomized controlled trial
Section titled “Randomized controlled trial”A study that assigns participants to groups by chance. This wiki marks evidence grade A only when such a trial is the cited design.
Research use only
Section titled “Research use only”A label some sellers put on products. The U.S. notes page records one FDA warning and is not a full legal opinion.
Resting heart rate
Section titled “Resting heart rate”Heart rate measured at rest. A wearable’s resting-heart-rate feature needs its own validation.
Section 503A
Section titled “Section 503A”A U.S. drug-compounding section of the Federal Food, Drug, and Cosmetic Act. The statute text was not pasted here.
Section 503B
Section titled “Section 503B”The U.S. section covering outsourcing facilities that compound drugs. The statute text was not pasted here.
Cellular senescence
Section titled “Cellular senescence”A cell state named as one of twelve hallmarks in the 2023 abstract on the hallmarks page.
Senolytic
Section titled “Senolytic”A proposed approach aimed at senescent cells. No drug is recommended, and no result is stated in this glossary.
Spinal cord stimulation
Section titled “Spinal cord stimulation”Electrical stimulation of the spinal cord, named by the International Neuromodulation Society as a neuromodulation example.
Steady-state visual evoked potential, a brain response to a flickering stimulus used in some EEG interfaces.
Stentrode
Section titled “Stentrode”A name used by Synchron for an endovascular interface. Specifications are on the stub device page only as an outline.
Targeted muscle reinnervation
Section titled “Targeted muscle reinnervation”A surgical rerouting of nerves to muscle so that EMG signals can drive a prosthesis. Technique is not described.
Transcranial direct current stimulation
Section titled “Transcranial direct current stimulation”A weak electrical current passed across the scalp. Parameters and home setups are intentionally absent.
Transcranial magnetic stimulation
Section titled “Transcranial magnetic stimulation”Stimulation of the brain with a magnetic coil. Cleared indications are not listed in this glossary.
Repetitive TMS
Section titled “Repetitive TMS”TMS delivered as a train of pulses. Protocols are not described.
Theta-burst stimulation
Section titled “Theta-burst stimulation”A patterned form of magnetic stimulation. Parameters are not stated.
Transcranial alternating current stimulation
Section titled “Transcranial alternating current stimulation”An alternating current applied through scalp electrodes. Parameters are not stated.
Transcutaneous auricular vagus nerve stimulation
Section titled “Transcutaneous auricular vagus nerve stimulation”Stimulation aimed at the vagus nerve through the skin of the ear. Device settings are not stated.
Vagus nerve stimulation
Section titled “Vagus nerve stimulation”Stimulation of the vagus nerve, implanted or through the skin. Indications are not listed in this glossary.
Utah array
Section titled “Utah array”An intracortical electrode array associated in public materials with Blackrock Neurotech. Specs are not copied.
VO2max
Section titled “VO2max”A measure of maximal oxygen uptake during exercise. A watch estimate is not the laboratory measurement.
Wearable
Section titled “Wearable”A device worn on the body that records or displays signals. Validation has to be read study by study.
Warning letter
Section titled “Warning letter”A public FDA letter alleging violations. The letter itself is the source, not a wiki summary.
510(k)
Section titled “510(k)”A U.S. FDA premarket notification used to claim a device is substantially equivalent to a predicate. A clearance is device-specific.
Hallmark of aging
Section titled “Hallmark of aging”One of the twelve processes named in the PubMed 36599349 abstract, summarized on the hallmarks page.
Nutrient sensing
Section titled “Nutrient sensing”Deregulated nutrient-sensing is one of the twelve hallmarks named in that abstract.
Proteostasis
Section titled “Proteostasis”Protein homeostasis. Loss of proteostasis is one of the twelve hallmarks named in that abstract.
Dysbiosis
Section titled “Dysbiosis”A disturbed microbiome, named as one of the twelve hallmarks in that abstract.
Gene therapy
Section titled “Gene therapy”A product intended to act through genetic material. FDA’s cellular and gene therapy center is the U.S. starting point. Methods are not described.
Cell therapy
Section titled “Cell therapy”A product made of cells. Clinic claims and preparation methods are not stated in this glossary.
NFC implant
Section titled “NFC implant”A small near-field-communication tag some people place under the skin. Placement is not described.
Radio-frequency identification. Subdermal use is not instructed.
Primary source
Section titled “Primary source”The document that states a fact: a paper, label, statute, or agency page. Wiki pages are not primary sources for each other.
Secondary source
Section titled “Secondary source”A summary of a primary document. This wiki labels it as secondary and does not treat it as the underlying data.
Interstitial glucose
Section titled “Interstitial glucose”Glucose in the fluid between cells, which many continuous monitors estimate. It is not identical to a laboratory blood glucose.
Pulse generator
Section titled “Pulse generator”The implanted electronics that the International Neuromodulation Society says drive stimulation leads.
Bulks list
Section titled “Bulks list”FDA’s list of bulk drug substances that may be used in compounding when statutory conditions are met. Being discussed is not the same as being listed.
Outsourcing facility
Section titled “Outsourcing facility”A U.S. compounding facility registered under section 503B. Obligations are in the statute, which was not pasted here.
MedWatch
Section titled “MedWatch”FDA’s program for reporting adverse events and product problems. The GLP-1 page points readers to it.
Green list
Section titled “Green list”On Import Alert 66-80, FDA’s list of GLP-1 API manufacturers excluded from that alert’s detention recommendation. Firm names are not copied here.
Salt form
Section titled “Salt form”The counter-ion attached to a drug substance. FDA says some semaglutide salts are not the approved active ingredient.
Page record
Stub, needs sourcing. This page does not yet contain enough checked facts to use as a reference.
Sources
No external sources are attached to this page.
Referenced by
A link from another wiki page is not evidence. Facts should point at the sources above.